[Retrospective study of lung carcinoid: experience in a third level Spanish hospital]

Rev Esp Patol. 2021 Apr-Jun;54(2):85-91. doi: 10.1016/j.patol.2020.04.004. Epub 2020 Oct 29.
[Article in Spanish]

Abstract

Introduction: Pulmonary carcinoids are relatively rare neuroendocrine neoplasms, accounting for only 1-2% of malignant thoracic tumours. We describe our experience in the management and follow-up of such an infrequent tumour, with special emphasis on possible problems that might arise.

Patients and methods: We present a descriptive retrospective study of all patients diagnosed with carcinoid tumour between January 2013 and January 2018. Demographic, histological and clinical data were collected and analyzed. Survival was recorded. SPSS version 21 was used for the statistical analysis.

Results: 42 patients with an average age of 66.26 years were included. The mean period of follow-up was 60 months and the average survival 59.12 months. The only statistically significant factor related to an improved survival time was tumour stage at diagnosis.

Conclusion: Carcinoid tumours are infrequent, which makes the objective collecting of data difficult. For this reason, we hope that the present study will contribute to a better understanding of their evolution.

Keywords: Cancer; Carcinoid; Carcinoide; Citología; Cytology.

MeSH terms

  • Aged
  • Carcinoid Tumor* / chemistry
  • Carcinoid Tumor* / mortality
  • Carcinoid Tumor* / pathology
  • Carcinoid Tumor* / surgery
  • Ex-Smokers / statistics & numerical data
  • Female
  • Humans
  • Lung Neoplasms* / chemistry
  • Lung Neoplasms* / mortality
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / surgery
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Non-Smokers / statistics & numerical data
  • Retrospective Studies
  • Smokers / statistics & numerical data
  • Spain
  • Survival Analysis
  • Tertiary Care Centers